Evidence map›Paper›PMID 35537536›Full record

ArticleThe Journal of infection2022

Comparative effects of mRNA vaccine booster and natural Omicron infection on the neutralizing antibody response.

Chloé Dimeglio, Marion Migueres, Sabine Chapuy-Regaud, Isabelle Da-Silva, Isabelle Jougla, Claire Pradere, Marion Porcheron, Guillaume Martin-Blondel, Catherine Lougarre, Fabrice Herin and 1 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Chloé DimeglioVirology Laboratory, CHU Toulouse, Hôpital Purpan, 31300 Toulouse, France; INSERM UMR1291 CNRS UMR5051, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), 31300 Toulouse, France. Electronic address: dimeglio.c@chu-toulouse.fr.
Marion MigueresVirology Laboratory, CHU Toulouse, Hôpital Purpan, 31300 Toulouse, France; INSERM UMR1291 CNRS UMR5051, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), 31300 Toulouse, France.
Sabine Chapuy-RegaudVirology Laboratory, CHU Toulouse, Hôpital Purpan, 31300 Toulouse, France.
Isabelle Da-SilvaVirology Laboratory, CHU Toulouse, Hôpital Purpan, 31300 Toulouse, France.
Isabelle JouglaOccupational Diseases Department, Toulouse University Hospital, 31000 Toulouse, France.
Claire PradereOccupational Diseases Department, Toulouse University Hospital, 31000 Toulouse, France.
Marion PorcheronVirology Laboratory, CHU Toulouse, Hôpital Purpan, 31300 Toulouse, France.
Guillaume Martin-BlondelINSERM UMR1291 CNRS UMR5051, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), 31300 Toulouse, France; Infectious and Tropical Diseases Department, Toulouse University Hospital, 31300 Toulouse, France.
Catherine LougarreCOVID Drive-Through Testing Center, Toulouse University Hospital, 31300 Toulouse, France.
Fabrice HerinOccupational Diseases Department, Toulouse University Hospital, 31000 Toulouse, France; UMR1295, Unité Mixte INSERM - Université Toulouse III Paul Sabatier, Centre for Epidemiology and Research in Population Health Unit (CERPOP), 31000 Toulouse, France.
Jacques IzopetVirology Laboratory, CHU Toulouse, Hôpital Purpan, 31300 Toulouse, France; INSERM UMR1291 CNRS UMR5051, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), 31300 Toulouse, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antibodies, NeutralizingAntibody FormationAntibodies, ViralHumansmRNA VaccinesVaccines, SyntheticAntibodies, NeutralizingAntibodies, ViralmRNA VaccinesVaccines, Synthetic

Identifiers

PMID35537536
PMCPMC9076577

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.